A Prospective Multi-centric Belgian Trial to Validate the Use of Golimumab Serum Level Analysis Using the Dried Blood Spot (DBS) Methodology
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Jan 2017 Status changed from not yet recruiting to recruiting.
- 29 Sep 2016 New trial record